柳药集团
(603368)
| 流通市值：66.69亿 | | | 总市值：66.69亿 |
| 流通股本：3.97亿 | | | 总股本：3.97亿 |
| 利润表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 营业总收入 | 16,143,614,506.95 | 10,526,113,932.73 | 5,377,272,243.65 | 20,926,270,790.4 |
| 营业总成本 | 15,483,207,929.52 | 10,091,091,101.37 | 5,065,165,311.08 | 20,015,831,005.51 |
| 其他经营收益 | | | | |
| 营业利润 | 659,048,383.69 | 434,226,105.32 | 275,808,800.3 | 882,385,074.27 |
| 利润总额 | 647,533,073.75 | 425,386,783.4 | 273,142,798.85 | 869,941,726.73 |
| 净利润 | 561,078,000.76 | 371,359,675.49 | 225,454,168.92 | 720,536,392.03 |
| 每股收益 | | | | |
| 其他综合收益 | - | - | - | - |
| 综合收益总额 | 561,078,000.76 | 371,359,675.49 | 225,454,168.92 | 720,536,392.03 |
| 资产负债表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 流动资产: | | | | |
| 流动资产合计 | 17,647,048,441.5 | 17,658,123,505.54 | 17,888,527,587.92 | 18,426,676,239.07 |
| 非流动资产: | | | | |
| 非流动资产合计 | 3,109,861,093.62 | 2,947,993,808.02 | 2,929,735,019.25 | 2,911,389,588.72 |
| 资产总计 | 20,756,909,535.12 | 20,606,117,313.56 | 20,818,262,607.17 | 21,338,065,827.79 |
| 流动负债: | | | | |
| 流动负债合计 | 10,918,096,347.46 | 11,026,430,037.89 | 11,176,884,107.8 | 12,220,977,439.5 |
| 非流动负债: | | | | |
| 非流动负债合计 | 1,466,343,280.65 | 1,389,828,628.42 | 1,327,067,955.83 | 975,050,345.3 |
| 负债合计 | 12,384,439,628.11 | 12,416,258,666.31 | 12,503,952,063.63 | 13,196,027,784.8 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 8,067,545,672.45 | 7,880,336,018.88 | 8,006,108,912.94 | 7,828,896,148.07 |
| 股东权益合计 | 8,372,469,907.01 | 8,189,858,647.25 | 8,314,310,543.54 | 8,142,038,042.99 |
| 负债和股东权益合计 | 20,756,909,535.12 | 20,606,117,313.56 | 20,818,262,607.17 | 21,338,065,827.79 |
| 现金流量表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 17,970,351,984.04 | 11,440,203,663.45 | 5,411,428,806.02 | 24,173,987,512.87 |
| 经营活动现金流出小计 | 17,781,660,950.19 | 11,304,676,448.53 | 5,920,580,373.11 | 23,096,328,583.51 |
| 经营活动产生的现金流量净额 | 188,691,033.85 | 135,527,214.92 | -509,151,567.09 | 1,077,658,929.36 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 1,056,254,623.91 | 1,055,522,110.84 | 225,023,841.9 | 1,245,182,145.33 |
| 投资活动现金流出小计 | 1,020,663,522.24 | 951,092,383.68 | 374,637,444.02 | 1,747,027,537.45 |
| 投资活动产生的现金流量净额 | 35,591,101.67 | 104,429,727.16 | -149,613,602.12 | -501,845,392.12 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | 5,601,742,561.17 | 4,223,948,675 | 2,087,769,468.85 | 6,592,259,050.32 |
| 筹资活动现金流出小计 | 6,652,665,835.1 | 4,833,962,306.06 | 2,970,245,908.19 | 7,224,325,936.37 |
| 筹资活动产生的现金流量净额 | -1,050,923,273.93 | -610,013,631.06 | -882,476,439.34 | -632,066,886.05 |
| 汇率变动对现金及现金等价物的影响 | - | - | - | - |
| 现金及现金等价物净增加额 | -826,641,138.41 | -370,056,688.98 | -1,541,241,608.55 | -56,253,348.81 |
| 期末现金及现金等价物余额 | 2,515,666,577 | 2,972,251,026.43 | 1,801,066,106.86 | 3,342,307,715.41 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | - | -370,056,688.98 | - | -56,253,348.81 |
最新报告期：2026-08-28| 研究机构 | 分析师 | 预测每股收益(元) | 更新日 |
| 2026年 | 2027年 | 2028年 |
| 华泰证券 | 代雯,孔垂岩,王殷杰 | 1.71 | 1.78 | 1.88 | 2026-08-28 |